rekrunner wrote:
They introduce risk when altitude is already providing high RBCs and benefit -- doesn't seem particularly smart. Is this what is considered rational?
You didn't read the paper I linked. EPO can increase Hb-mass above & beyond what altitude training can do.
https://pubmed.ncbi.nlm.nih.gov/30969231/"The desire to increase tHb-mass beyond levels that can be attained through altitude training (14) has led some athletes to use recombinant human erythropetin (rHuEpo). Within our group, rHuEpo has been shown to increase an individual’s V˙O2max by approximately 6% and endurance
performance by approximately 8% (15), with similar im-provements in V˙ O2max reported by others (16,17). The current method to detect rHuEpo involves longitudinal monitoring of an athlete’s hematological parameters, known as the Athlete Biological Passport (ABP), to detect changes that may indicate rHuEpo abuse (18). An aug-mented tHb-mass is considered the primary mechanism
responsible for the ergogenic effects of both rHuEpo use and altitude exposure (14). It is plausible that an athlete could administer rHuEpo to enhance the tHb-mass while attending an altitude training camp and attempt to explain any suspicious hematological change as a response to altitude. This tactic has previously been employed by an elite-level athlete, but it did not succeed as the height of the altitude (800Y1600 m) was insufficient to elicit a significant hematological response (19). The aim of this perspective is to highlight the pitfalls of current altitude training guidelines and summarize the difficulty antidoping agencies face in detecting rHuEpo abuse in athletes training at altitude."